World Journal of Surgery

, Volume 35, Issue 3, pp 698–699 | Cite as

Two-Stage Breast Cancer Screening in the Developing World

Article

References

  1. 1.
    Denewer A, Hussein O, Farouk O et al (2010) Cost-effectiveness of clinical breast assessment-based screening in rural Egypt. World J Surg 34:2204–2210CrossRefPubMedGoogle Scholar
  2. 2.
    Wacholder S, Hartge P, Prentice R et al (2010) Performance of common genetic variants in breast-cancer risk models. N Engl J Med 362:986–993CrossRefPubMedGoogle Scholar
  3. 3.
    Ziogas D, Roukos DH (2009) Genetics and personal genomics for personalized breast cancer surgery: progress and challenges in research and clinical practice. Ann Surg Oncol 16(7):1771–1782CrossRefPubMedGoogle Scholar
  4. 4.
    Katsios C, Roukos DH (2010) Individual genomes and personalized medicine: life diversity and complexity. Per Med 7(4):347–350CrossRefGoogle Scholar
  5. 5.
    Roukos DH, Ziogas D (2010) From tumor size and HER2 status to systems oncology for very early breast cancer treatment. Expert Rev Anticancer Ther 10(2):123–128CrossRefPubMedGoogle Scholar
  6. 6.
    Roukos DH (2010) Complete genome sequencing and network modeling to overcome trastuzumab resistance. Pharmacogenomics 11(8):1039–1043CrossRefPubMedGoogle Scholar
  7. 7.
    Roukos DH (2010) Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice. Biomark Med 4(4):583–586CrossRefPubMedGoogle Scholar
  8. 8.
    Roukos DH, Katsios C, Liakakos T (2010) Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment. Expert Rev Mol Diagn 10(5):541–545CrossRefPubMedGoogle Scholar
  9. 9.
    Roukos DH (2010) Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn 10(3):247–250CrossRefPubMedGoogle Scholar
  10. 10.
    Roukos DH (2010) Systems medicine: a real approach for future personalized oncology? Pharmacogenomics 11(3):283–287CrossRefPubMedGoogle Scholar
  11. 11.
    Roukos DH (2010) Novel clinico-genome network modeling for revolutionizing genotype-phenotype-based personalized cancer care. Expert Rev Mol Diagn 10(1):33–48CrossRefPubMedGoogle Scholar
  12. 12.
    Roukos DH (2009) Isolated tumor cells in breast cancer. N Engl J Med 361:1994–1995; author reply 1995-6Google Scholar
  13. 13.
    Roukos DH, Tzakos A, Zografos G (2009) Current concerns and challenges towards tailored anti-angiogenic therapy in cancer. Expert Rev Anticancer Ther 9(10):1413–1416CrossRefPubMedGoogle Scholar
  14. 14.
    Roukos DH, Ziogas D (2009) Human genetic and structural genomic variation: would genome-wide association studies be the solution for cancer complexity like Alexander the Great for the “Gordian Knot”? Ann Surg Oncol 16(3):774–775CrossRefPubMedGoogle Scholar
  15. 15.
    Roukos DH (2010) Targeting gastric cancer with trastuzumab: new clinical practice and innovative developments to overcome resistance. Ann Surg Oncol 17:14–17CrossRefPubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2010

Authors and Affiliations

  1. 1.Department of Surgery, School of MedicineUniversity of IoanninaIoanninaGreece

Personalised recommendations